XILITY
LIVE

Serial Number

98661992

Owner

Roche Molecular Systems, Inc.

Attorney

Mona Gupta

Filing Date

Jul 23, 2024

Add to watchlist:

No watchlists yet
View on USPTO

XILITY Trademark

Serial Number: 98661992

XILITY is a trademark filed by Roche Molecular Systems, Inc. on July 23, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Roche Molecular Systems, Inc. (2 trademarks)

4300 HACIENDA DRIVE
Pleasanton, CA 94588

Entity Type: 03

Trademark Details

Filing Date

July 23, 2024

Registration Date

Not Registered

Published for Opposition

February 25, 2025

Goods & Services

Clinical or medical diagnostic apparatus and instruments, namely, nucleic acid sequencers, imaging devices and analyzers; medical diagnostic apparatus and instruments for the amplification and analysis of nucleic acids and the preparation of nucleic acid libraries sold together in the form of kit; medical equipment, namely, devices for analyzing nucleic acids and for dna sequencing for the purpose of rendering medical treatment and diagnosis, and downloadable software for use therewith sold as a unit

In vitro diagnostic agents, namely, reagents and control solutions for analysis of biological samples, all for medical diagnostic purposes; reagents for medical diagnostic use; medical diagnostic assays and reagents for testing of biological samples; reagent kits consisting of enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides, buffers, labels, and substrates for medical diagnostic purposes; medical diagnostic test kits comprising reagents for genetic testing; chemical reagents, preparations and test kits for nucleic acid analysis for medical use; diagnostic kits consisting primarily of reagents for nucleic acid detection and analysis for medical diagnostic purposes; reagents for medical diagnostic use and diagnostic kits comprised of medical diagnostic reagents and assays for use in connection with dna sequencing and genetic analysis

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 21, 2026 EXRA
SOU EXTENSION 2 GRANTED
Apr 20, 2026 EX2G
SOU EXTENSION 2 FILED
Apr 20, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 20, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 9, 2025 EXRA
SOU EXTENSION 1 GRANTED
Oct 8, 2025 EX1G
SOU EXTENSION 1 FILED
Oct 8, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 8, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 22, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 3, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 3, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 3, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 3, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 3, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 30, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2025 NWOS
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 10, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 10, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 10, 2024 REAP
NEW APPLICATION ENTERED
Jul 23, 2024 NWAP